From 2002 to 2007 , the International Berlin-Frankfurt-Mnster Study Group conducted a prospective randomized clinical trial ( ALL IC-BFM 2002 ) for the management of childhood acute lymphoblastic leukemia ( ALL ) in 15 countries on three continents .